Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk

Karsten Schulmann, Anca Sterian, Agnes Berki, Jing Yin, Fumiaki Sato, Yan Xu, Andreea Olaru, Suna Wang, Yuriko Mori, Elena Deacu, James Hamilton, Takatsugu Kan, Mark J. Krasna, David G. Beer, Margaret S. Pepe, John M. Abraham, Ziding Feng, Wolff Schmiegel, Bruce D. Greenwald, Stephen J. Meltzer

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk'. Together they form a unique fingerprint.

Medicine & Life Sciences